KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$1.36.

  • Cardlytics' EPS (Basic) rose 5310.34% to -$1.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.05, marking a year-over-year increase of 6740.86%. This contributed to the annual value of -$3.91 for FY2024, which is 608.11% down from last year.
  • Latest data reveals that Cardlytics reported EPS (Basic) of -$1.36 as of Q3 2025, which was up 5310.34% from -$0.18 recorded in Q2 2025.
  • In the past 5 years, Cardlytics' EPS (Basic) ranged from a high of $0.98 in Q1 2022 and a low of -$11.32 during Q4 2022
  • Its 5-year average for EPS (Basic) is -$1.43, with a median of -$0.63 in 2023.
  • Within the past 5 years, the most significant YoY rise in Cardlytics' EPS (Basic) was 21529.41% (2022), while the steepest drop was 298007.3% (2022).
  • Over the past 5 years, Cardlytics' EPS (Basic) (Quarter) stood at -$0.37 in 2021, then tumbled by 2980.07% to -$11.32 in 2022, then skyrocketed by 75.8% to -$2.74 in 2023, then soared by 88.24% to -$0.32 in 2024, then plummeted by 321.91% to -$1.36 in 2025.
  • Its last three reported values are -$1.36 in Q3 2025, -$0.18 for Q2 2025, and -$0.26 during Q1 2025.